drugset / Trial / NCT02247596

Effects of High-Dose Resveratrol in Non-Diabetic Obese Males

NCT02247596

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary aim of our study was to examine the effects of two weeks of oral resveratrol on resting energy expenditure and insulin sensitivity in non-diabetic obese male subjects. Secondary variables included plasma lipid subfraction, blood pressure and glycated hemoglobin (HbA1c).

Timeline

Start
2009-07
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Resveratrol Small molecule 1 g Oral